#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4273391	B	Inhibition of HIV1 reverse transcriptase RNaseH activity using 3'-fluorescein/5'-Dabcyl labeled HTS-1 substrate	Human immunodeficiency virus 1	49		single protein format	Scientific Literature
2.	ALA4273392	B	Inhibition of HIV1 reverse transcriptase polymerase activity using 18 nucleotide DNA primer and 100 nucleotide DNA template after 30 mins	Human immunodeficiency virus 1	49		single protein format	Scientific Literature
3.	ALA4273393	B	Inhibition of HIV integrase strand transfer activity using 5'-biotin/3'-Cy5-labeled DNA substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by HTS assay	Human immunodeficiency virus	49		single protein format	Scientific Literature
4.	ALA4273394	B	Selectivity index, ratio of IC50 for HIV integrase strand transfer activity to IC50 for HIV1 reverse transcriptase RNaseH activity		44		assay format	Scientific Literature
5.	ALA4273395	F	Antiviral activity against HIV1 infected in CD4/CXCR4/CCR5 expressing human P4R5 MAGI cells preincubated with cells for 24 hrs followed by viral infection measured after 48 hrs by beta-galactosidase reporter gene assay	Human immunodeficiency virus 1	44		organism-based format	Scientific Literature
6.	ALA4273397	A	Cytotoxicity against human P4R5 MAGI cells	Homo sapiens	42		cell-based format	Scientific Literature
7.	ALA4824588	B	Inhibition of human cytomegalovirus pUL89 endonuclease activity using 60 bp dsDNA substrate at 20 uM incubated for 30 mins by ELISA-based biochemical assay relative to control	Human betaherpesvirus 5	42		single protein format	Scientific Literature
8.	ALA4824589	F	Antiviral activity against human cytomegalovirus expressing ADCREGFP infected in human HEL 299 cells assessed as reduction in viral replication by measuring GFP fluorescence at 10 uM incubated for 168 hrs by cell based assay relative to control	Human betaherpesvirus 5	43		cell-based format	Scientific Literature
9.	ALA4824590	A	Cytotoxicity against human HEL 299 cells assessed as cell viability at 10 uM incubated for 168 hrs by MTS-based tetrazolium reduction assay relative to control	Homo sapiens	43		cell-based format	Scientific Literature
10.	ALA4824591	B	Inhibition of human cytomegalovirus pUL89 endonuclease activity using 60 bp dsDNA substrate incubated for 30 mins by ELISA-based biochemical assay	Human betaherpesvirus 5	24		single protein format	Scientific Literature
11.	ALA4824592	B	Binding affinity to human cytomegalovirus pUL89 assessed as change in melting temperature at 20 uM by thermal shift assay	Human betaherpesvirus 5	25		single protein format	Scientific Literature
12.	ALA4824593	A	Apparent permeability of the compound incubated for 5 hrs by LC-MS/MS analysis based PAMPA method		13		assay format	Scientific Literature
13.	ALA4824594	F	Antiviral activity against human cytomegalovirus expressing ADCREGFP infected in human HEL 299 cells assessed as reduction in viral replication by measuring GFP fluorescence incubated for 168 hrs by cell based assay	Human betaherpesvirus 5	14		cell-based format	Scientific Literature
14.	ALA4824595	A	Cytotoxicity against human HEL 299 cells assessed as cell death incubated for 168 hrs by MTS-based tetrazolium reduction assay	Homo sapiens	14		cell-based format	Scientific Literature
15.	ALA4824596	T	Selectivity index, ratio of CC50 for human HEL 299 cells to EC50 for antiviral activity against human cytomegalovirus expressing ADCREGFP infected in human Hel-299 cells assessed as reduction in viral replication by measuring GFP fluorescence incubated for 168 hrs by cell based assay		14		cell-based format	Scientific Literature